Tissue Level vs Bone Level Implants for Plural Restorations : a Multicentre Randomised Controlled Trial
IBERICA
1 other identifier
interventional
40
2 countries
3
Brief Summary
Anthogyr Axiom Tissue-Level implants and corresponding Multi-Unit abutments recently enriched the available product range for dental surgeons. This Post-Market Clinical Follow-Up study aims at confirming the safety and performance of these products. The comparison with similar Anthogyr Axiom Bone-level implants will provide additional information on the effect of platform-switching in bone level maintenance for single and two-piece design at the implant level.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2022
Longer than P75 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 21, 2022
CompletedFirst Posted
Study publicly available on registry
February 4, 2022
CompletedStudy Start
First participant enrolled
March 30, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 18, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 18, 2027
ExpectedMarch 19, 2025
March 1, 2025
3.3 years
January 21, 2022
March 17, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Marginal Bone Level Change
Change in crestal bone level measured by analysis of standardized peri-apical xrays \[mm\].
6 months,12 months, and 3 years after loading
Secondary Outcomes (3)
Implant survival
6 months,12 months, and 3 years after loading
Prosthesis Survival
6 months,12 months, and 3 years after prosthesis placement
14 item Oral Health Impact Profile (OHIP-14)
screening visit, 6, 12 months and 3 years after loading
Other Outcomes (2)
Adverse Events
3 years after inclusion
Device Deficiencies
3 years after inclusion
Study Arms (2)
Study Group
EXPERIMENTALAnthogyr Axiom TL REG and corresponding Multi-Unit abutments
Control Group
ACTIVE COMPARATORAnthogyr Axiom BL REG and corresponding Multi-Unit abutment
Interventions
Anthogyr AXIOM TL Reg will be placed in healed bone crests in the mandible or maxilla for multiple teeth replacement, followed by a provisional prosthesis immediately loaded, if the patient needs a provisional. In each case, the MU abutment will be placed immediately after implant placement. Multi-Unit abutments are used to fix the prosthesis
Axiom BL Reg implants will be placed in healed bone crests in the mandible or maxilla for multiple teeth replacement, followed by a provisional prosthesis immediately loaded, if the patient needs a provisional. In each case, the MU abutment will be placed immediately after implant placement. Multi-Unit abutments are used to fix the prosthesis
Eligibility Criteria
You may qualify if:
- Patients must have voluntarily signed the Informed Consent Form before any study related procedures are performed, are willing and able to attend scheduled follow-up visits and agree that the pseudonymized data are collected and analyzed.
- Patients must be males or females who are a minimum of 18 years of age.
- Patients with a minimum of 4 weeks history of edentulism in the study area, in need of a multiple teeth replacement with dental implants
- Patients with complete soft tissue coverage of the socket at implant placement
You may not qualify if:
- Uncontrolled systemic disease that would interfere with dental implant therapy (e.g. uncontrolled diabetes)
- Any contraindications for oral surgical procedures
- History of local irradiation therapy in the head / neck area
- Patients who are currently heavy smokers (defined \>10 cigarettes per day or \>1 cigar per day), or have ≥ 20 pack years who use chewing tobacco
- Medical conditions requiring chronic high dose steroid therapy or high dose anti-resorptive treatment
- Subjects who have undergone administration of any investigational device within 30 days of enrolment in the study
- Conditions or circumstances, in the opinion of the investigator, which would prevent completion of study participation or interfere with analysis of study results, such as history of non-compliance or unreliability
- Cognitive impairment that would interfere with the ability to perform adequate oral hygiene (assessed by Ottawa 3DY scale)
- Patients with chronic pain
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Anthogyrlead
Study Sites (3)
Faculdade de Medicina Dentária da Universidade do Porto
Porto, Portugal
Universidad International de Catalunya
Barcelona, Spain
Universidad de Santiago de Compostela
Santiago de Compostela, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Juan Blanco Carrión, Pr.Dr.
Universidad de Santiago de Compostela
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 21, 2022
First Posted
February 4, 2022
Study Start
March 30, 2022
Primary Completion
July 18, 2025
Study Completion (Estimated)
July 18, 2027
Last Updated
March 19, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share